Neil Gregory Almstead Form 4 PTC THERAPEUTICS / Neil Gregory Almstead ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Almstead Neil Gregory

(Last) (First) (Middle)

C/O PTC THERAPEUTICS, INC.

100 CORPORATE COURT

(Street)

SOUTH PLAINFIELD NJ 07080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PTC THERAPEUTICS, INC. [ PTCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
EVP Research Pharma Ops & Tech

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2015

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/15/2015		S(1)		5,400	D	$68.35(2)	4,111	D
Common Stock	04/15/2015		S(1)		4,111	D	$69.04(3)	0	D
Common Stock								1,295	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$51							(4)	01/01/2025	Common Stock	69,550		69,550	D
Stock Option (Right to Buy)	$27.05							(5)	01/27/2024	Common Stock	40,000		40,000	D
Stock Option (Right to Buy)	$10.85							(6)	05/15/2023	Common Stock	70,312		70,312	D
Stock Option (Right to Buy)	$10.85							(7)	05/15/2023	Common Stock	9,688		9,688	D
Stock Option (Right to Buy)	$218.4							(8)	01/10/2022	Common Stock	166		166	D
Stock Option (Right to Buy)	$490.8							(9)	04/27/2021	Common Stock	216		216	D
Stock Option (Right to Buy)	$1,149.6							(9)	02/02/2020	Common Stock	200		200	D
Stock Option (Right to Buy)	$451.2							(9)	05/15/2019	Common Stock	200		200	D
Stock Option (Right to Buy)	$735.6							(9)	04/01/2018	Common Stock	194		194	D
Stock Option (Right to Buy)	$735.6							(9)	01/25/2018	Common Stock	166		166	D
Stock Option (Right to Buy)	$626.4							(9)	04/18/2017	Common Stock	137		137	D
Stock Option (Right to Buy)	$392.4							(9)	03/01/2016	Common Stock	119		119	D
Stock Option (Right to Buy)	$226.8							(9)	05/24/2015	Common Stock	106		106	D
Stock Option (Right to Buy)	$51							(4)	01/01/2025	Common Stock	2,060		2,060	I	By spouse
Stock Option (Right to Buy)	$27.05							(5)	01/27/2024	Common Stock	1,300		1,300	I	By spouse
Stock Option (Right to Buy)	$10.85							(10)	05/15/2023	Common Stock	600		600	I	By spouse
Stock Option (Right to Buy)	$218.4							(8)	01/10/2022	Common Stock	7		7	I	By spouse
Stock Option (Right to Buy)	$490.8							(9)	04/27/2021	Common Stock	7		7	I	By spouse
Stock Option (Right to Buy)	$1,149.6							(9)	02/02/2020	Common Stock	1		1	I	By spouse
Stock Option (Right to Buy)	$508.8							(9)	10/07/2019	Common Stock	12		12	I	By spouse

Explanation of Responses:

1. The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.

2. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.74 to $68.60 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

3. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.79 to $69.65 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

4. This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.

5. This option was granted on January 28, 2014, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.

6. This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on June 15, 2014.

7. This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on January 31, 2014.

8. This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting quarterly thereafter beginning on April 1, 2013.

9. Currently exercisable.

10. This option was granted on May 15, 2013 and vests over two years, with 50% of the shares underlying the option vested on May 15, 2014 and the remaining 50% of the original number of shares underlying the option vesting on May 15, 2015.

	/s/ Colleen Diver Johnson, attorney-in-fact	04/17/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.